Thyroid function in patients with Alzheimer's disease treated with cholinesterase inhibitors

Kapaki, E; Ilias, I; Paraskevas, GP; Theotoka, I; Christakopoulou, I

dc.contributor.author	Kapaki, E	en
dc.contributor.author	Ilias, I	en
dc.contributor.author	Paraskevas, GP	en
dc.contributor.author	Theotoka, I	en
dc.contributor.author	Christakopoulou, I	en
dc.date.accessioned	2014-03-01T01:53:14Z
dc.date.available	2014-03-01T01:53:14Z
dc.date.issued	2003	en
dc.identifier.issn	0065-1400	en
dc.identifier.uri	https://dspace.lib.ntua.gr/xmlui/handle/123456789/26895
dc.subject	cholinesterase inhibitors	en
dc.subject	Alzheimer's disease	en
dc.subject	thyroid function tests	en
dc.subject.classification	Neurosciences	en
dc.subject.other	TRH STIMULATION TEST	en
dc.subject.other	DEMENTIA	en
dc.subject.other	BRAIN	en
dc.subject.other	ACETYLCHOLINE	en
dc.subject.other	COGNITION	en
dc.subject.other	HORMONES	en
dc.title	Thyroid function in patients with Alzheimer's disease treated with cholinesterase inhibitors	en
heal.type	journalArticle	en
heal.language	English	en
heal.publicationDate	2003	en
heal.abstract	The aim of the present study was to explore a possible interplay between cholinesterase inhibitors (ChEIs) and thyroid function tests (TFTs) in patients with Alzheimer's disease (AD). We reviewed thyroid function tests in 19 patients with AD before and after treatment (Rx) with ChEIs. Immunoradiometric assays were used for measuring serum thyrotropin, free thyroxin (FT4) and free triiodothyronine (FT3). Significant differences were observed among FT3 levels according to the duration of therapy. Subtle variations in thyroid function tests - before and after therapy - could be possibly related to ChEIs-induced altered thyroid function.	en
heal.publisher	NENCKI INST EXPERIMENTAL BIOLOGY	en
heal.journalName	ACTA NEUROBIOLOGIAE EXPERIMENTALIS	en
dc.identifier.isi	ISI:000187197100011	en
dc.identifier.volume	63	en
dc.identifier.issue	4	en
dc.identifier.spage	389	en
dc.identifier.epage	392	en